Figure 6.
IL18 is involved in the progression of COVID-19, and the methylation pattern of PBMC changes after infection. (A) Expression of IL18 in patients with different clinical severity of COVID-19(mild:5 patients; moderate:6 patients; serious: 4 patients; p=0.367; Games-Howell test) (B) Expression of IL18 in patients with different stage of COVID-19(convalescence:14 patients; rehabilitation:9 patients; treatment: 15 patients; p=0.079; Games-Howell test) (C) Heat map of PBMC methylation differential sites after SARS-CoV-2 infection (D) Enrichment analysis of differential methylation sites after SARS-CoV-2 infection. (Pvalue<0.05).